Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2018: 3.014
5-year IMPACT FACTOR: 3.162

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 384, Issue 3

Issues

Structure-Activity Relationships of Glucose-Dependent Insulinotropic Polypeptide (GIP)

S.A. Hinke / R. Gelling / S. Manhart / F. Lynn / R.A. Pederson / K. Kühn-Wache / F. Rosche / H.-U. Demuth / D. Coy / C.H.S. McIntosh
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.2003.046

Abstract

Six GIP1-30NH2 analogs were synthesized with modifications (de-protonation, N-methylation, reversed chirality, and substitution) at positions 1, 3, and 4 of the N-terminus, and additionally, a cyclized GIP derivative was synthesized. The relationship between altered structure to biological activity was assessed by measuring receptor binding affinity and ability to stimulate adenylyl cyclase in CHO-K1 cells transfected with the wild-type GIP receptor (wtGIPR). These structureactivity relationship studies demonstrate the importance of the GIP N-terminus and highlight structural constraints that can be introduced in GIP analogs. These analogs may be useful starting points for design of peptides with enhanced in vivo bioactivity.

About the article

Published Online: 2005-06-01

Published in Print: 2003-03-14


Citation Information: Biological Chemistry, Volume 384, Issue 3, Pages 403–407, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2003.046.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Samuel A. Mantey, Nieves Gonzalez, Michael Schumann, Tapas K. Pradhan, Lin Shen, David H. Coy, and Robert T. Jensen
Journal of Pharmacology and Experimental Therapeutics, 2006, Volume 319, Number 2, Page 980
[2]
Tahir Yaqub, Irina G. Tikhonova, Jens Lättig, Remi Magnan, Marie Laval, Chantal Escrieut, Cyril Boulègue, Chandralal Hewage, and Daniel Fourmy
Molecular Pharmacology, 2010, Volume 77, Number 4, Page 547
[3]
Mi Jin Moon, Hee Young Kim, Sumi Park, Dong-Kyu Kim, Eun Bee Cho, Cho Rong Park, Dong-Joo You, Jong-Ik Hwang, Kyungjin Kim, Han Choe, and Jae Young Seong
Journal of Biological Chemistry, 2012, Volume 287, Number 6, Page 3873
[4]
S. Al-Sabah, M. Al-Fulaij, and H.A. Ahmed
European Journal of Pharmacology, 2014, Volume 741, Page 311
[5]
J.-I. Hwang, S. Yun, M. J. Moon, C. R. Park, and J. Y. Seong
Journal of Molecular Endocrinology, 2014, Volume 52, Number 3, Page T15
[6]
Victor A. Gault, Kerry Hunter, Nigel Irwin, Brian D. Green, Brett Greer, Patrick Harriott, Finbarr P.M. O’Harte, and Peter R. Flatt
Archives of Biochemistry and Biophysics, 2007, Volume 461, Number 2, Page 263
[7]
Christine M.A. Martin, Victor A. Gault, Stephen McClean, Peter R. Flatt, and Nigel Irwin
Biochemical Pharmacology, 2012, Volume 84, Number 3, Page 312
[8]
Victor A. Gault, Finbarr P.M. O’Harte, and Peter R. Flatt
Neuropeptides, 2003, Volume 37, Number 5, Page 253
[9]
Victor A. Gault, Peter R. Flatt, and Finbarr P.M. O’Harte
Biochemical and Biophysical Research Communications, 2003, Volume 308, Number 2, Page 207
[10]
Simon A Hinke, Susanne Manhart, Madeleine Speck, Raymond A Pederson, Hans-Ulrich Demuth, and Christopher H.S McIntosh
Life Sciences, 2004, Volume 75, Number 15, Page 1857
[11]

Comments (0)

Please log in or register to comment.
Log in